Registration for the April 25/26th FDA meeting has closed but you can still provide comments directly to the FDA
- Go here and submit comments now by clicking on the ‘Comment Now!” box in the upper right corner of the page.
- You can also submit written comments to Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Include the docket number, which is “FDA-2012-N-0962-0004”.
- The Docket is open until August 2, 2013.
- The FDA is encouraging patients to provide answers to the questions asked in the Federal Register. But again, don’t forget to also include information about the biological abnormalities – linked to symptoms where possible – and indicate how those abnormalities changed as a result of treatment if known.